chenguang chenguang

Company News

Media info

Bidding information

The group company held a grand 2024 annual summary and commendation conference

At the end of the year, warm sunshine greets spring with great coldness. On January 22nd, the conference hall on the third floor of Quzhou Guesthouse was brightly lit and the atmosphere was very lively, the 2024 annual summary and commendation conference of the group company was held here. Company leaders attended the meeting, with department heads, employees of various systems, heads of subsidiaries, and employee representatives in attendance.
At 8:30 AM, company leaders Lu Qingguo, Li Fengfei, Lian Yunhe, and Zhou Jing walked onto the podium and took their seats, and the conference begun. Li Fengfei, the deputy general manager presiding over the meeting, read out 《the Group's Decision on Commending Advanced Work Pacesetter and exemplary individual in 2024》. The staff delivered promotional speeches for advanced work models Xu Meili, Yang Fuguang, Ye Luzhou, and Wu Zaiqiang, and Chairman and General Manager Mr.Lu Qingguo presented them with honorary certificates and trophies.
Amidst the warm applause, Mr. Lu delivered an important speech on the summary of work for 2024 and the arrangement of work for 2025. First of all, he congratulated the advanced work pacesetters and exemplary individual who had made outstanding achievements in the past year. On behalf of the leaders of the Group, he extended his festive wishes to all Chenguang employees who have worked hard at various posts at home and abroad for the past year! Sincere condolences to the employees in India, Zambia, Myanmar, and other parts of the country who have remained at their posts during the Spring Festival! Sincere thanks to the families of employees, leaders at all levels, customers, partners, and friends from all walks of life who support the development of Chenguang Biotech business! He reviewed the past year when facing a severe and complex international situation. The brave and enterprising members of the Chenguang Biotech team, with extraordinary perseverance and wisdom, overcame difficulties and forged ahead. With the joint efforts of all employees, the company's annual sales revenue in 2024 was about 7 billion yuan, reaching a new historical high.
Mr. Lu summarized the work for 2024 from five aspects: Firstly, steady development of business operations and continuous consolidation of market position; 2、 Technological improvement to reduce costs and increase efficiency, and continuous empowerment of project construction; 3、 Scientific research projects are steadily advancing, and innovative achievements are emerging one after another; 4、 The institutional system continues to improve and management efficiency steadily increases; 5、 Diversified talent strategies and remarkable achievements in cultural construction.
Regarding the work for 2025, Mr. Lu has made the following arrangements: 1. To make steady progress in business management and lead the healthy development of the industry; 2、 Adhere to the concept of technological innovation and promote the transformation and upgrading of enterprises; 3、 Deepen project strategic planning and accelerate the application and transformation of results; 4、 Continuously improving the management system and enhancing the level of management; 5、 Building a talent innovation field to support the steady development of enterprises.
Finally, Mr. Lu said that in the New Year, challenges and opportunities coexist. Faced with new development tasks, we must firmly establish our confidence in development, enhance our own capabilities, break through the waves, sail forward bravely, and unswervingly continue to move towards the grand goal of "building a world natural extract industry base and contributing to human health"!